DCF — MORRISTOWN MEDICAL CENTER
Enterprise Value: $1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$1.5B
Enterprise Value
$395.0M
PV of Cash Flows
$1.1B
PV of Terminal Value
$1.8B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.8B | $188.5M | 11.0% | $78.2M | $71.1M |
| Year 2 | $1.8B | $212.2M | 12.0% | $94.1M | $77.8M |
| Year 3 | $1.9B | $237.1M | 13.0% | $110.9M | $83.3M |
| Year 4 | $1.9B | $253.8M | 13.0% | $121.4M | $82.9M |
| Year 5 | $2.0B | $266.3M | 14.0% | $128.7M | $79.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $1.5B. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.7B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.10271711050517895
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5